Skip to main content

Roche Diagnostics Constructs PCR Manufacturing Center

Published 9/30/2004

Design of Roche Diagnostic 's new 440,000-sf PCR Manufacturing Center in Branchburg, N.J., is nearing completion. PCR (Polymerase Chain Reaction) is leading-edge technology in the field of molecular diagnostics. The facility will include a new state-of-the-art 230,000-sf pharmaceutical manufacturing center, a 32,000-sf office building (completed), and the renovation of a 180,000-sf existing laboratory and office headquarters for Roche Molecular Systems. The manufacturing facility is slated for completion in November 2004.

 The building will employ a patented technology for the development and production of biochemical reagents, and the manufacture of diagnostic kits used by HIV patients to monitor the effects of daily medications. Program elements include a new cGMP manufacturing facility; production testing laboratories, including Class 1000 cleanroom environments; offices; central shipping, receiving and warehouse; central energy plant; kit assembly area; and library/cafeteria. This new $140-million mixed-use complex is designed by Einhorn Yaffee Prescott, the firm primarily responsible for overall master planning of the 63-acre campus. 

Organization
EYP Architecture & Engineering